| 产品详情 |
| Edit |   |
|---|
| Antigenic Specificity | Bcl-2 |
|---|
| Clone | 100/D5 |
|---|
| Host Species | Mouse |
|---|
| Reactive Species | human |
|---|
| Isotype | IgG1 kappa |
|---|
| Format | Protein G purified |
|---|
| Size | 0.2 mg |
|---|
| Concentration | 0.2 mg/ml |
|---|
| Applications | Western Blot, Flow Cytometry, ELISA, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen. Human Chromosome Location: 18q21.33 Staining of formalin-fixed tissues REQUIRES boiling tissue sections in 1mM EDTA, pH 8.0 for 10-20 min followed by cooling at RT for 20 min. Epitope unmasking in EDTA (compared to Citrate buffer) is superior. Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Frozen and Immunoprecipitation applications reported in literature. |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | The Bcl-2 Antibody (100/D5) from Novus Biologicals is a mouse monoclonal antibody to Bcl-2. This antibody reacts with human, mouse (negative), rat (negative). The Bcl-2 Antibody (100/D5) has been validated for the following applications: Western Blot, Flow Cytometry, ELISA, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen. |
|---|
| Immunogen | The synthetic peptide corresponding to amino acids range from 41-64 (GAAPAPGIFSSQPG-Cys), of human Bcl-2 was used as immunogen to generate the antibody; GenBank no. NP_000648.2 (Pezzella et al, 1990). |
|---|
| Other Names | apoptosis regulator Bcl-2, B-cell CLL/lymphoma 2, Bcl-2 |
|---|
| Gene, Accession # | BCL2, Gene ID: 596, Accession: P10415, SwissProt: P10415 |
|---|
| Catalog # | NBP2-15200-0.2mg |
|---|
| Price | |
|---|
| Order / More Info | Bcl-2 Antibody from NOVUS BIOLOGICALS, LLC |
|---|
| Product Specific References | PubMed: 14692814, 15163019, 2201196, 22257663, 22309998, 24804954, 30684525 |
|---|
| 产品资料 |
|
|